MED
On PubPhys: open
In the literature: partially resolved
Compiled by AI, not yet reviewed by an editor
Accelerator production routes for therapeutic alpha emitters
55No. 498 in all physics · No. 21 in Medical and Radiation Physics
The most promising alpha-emitting drugs are limited by how little of the isotope can be made. Which production reaction is best is not settled.
Status in the literature
Accelerator routes expanded supply after about 2018 while impurity control and scale-up remained limiting.
No solutions, ideas or subproblems yet.
Details, signature and history
- Kind
- Well-posed question
- Answer
- Value
- Posed
- 2010
- Topic review
- Sgouros, Bodei, McDevitt and Nedrow, Radiopharmaceutical therapy in cancer: clinical advances and challenges, Nature Reviews Drug Discovery, 2020. Link
- Record
- Revision 1 · imported from the seed collection · compiled by AI, not yet reviewed by an editor
Proof
- Fingerprint
- fc9752740fad…
- Public log
- Entry 1,722, in checkpoint 2,123
- In the log by
- Block 969,698, 2026-10-03
This text was in the PubPhys log by that date. The date says nothing about when the problem was first posed.
Comments (0)
Comments are not records: they are not signed, stamped or logged. How comments work
No comments yet.
Sign in to comment.